297 related articles for article (PubMed ID: 19520047)
1. Overexpression of follistatin in human myoblasts increases their proliferation and differentiation, and improves the graft success in SCID mice.
Benabdallah BF; Bouchentouf M; Rousseau J; Tremblay JP
Cell Transplant; 2009; 18(7):709-18. PubMed ID: 19520047
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice.
Benabdallah BF; Bouchentouf M; Rousseau J; Bigey P; Michaud A; Chapdelaine P; Scherman D; Tremblay JP
Cell Transplant; 2008; 17(3):337-50. PubMed ID: 18522236
[TBL] [Abstract][Full Text] [Related]
3. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
Fakhfakh R; Michaud A; Tremblay JP
Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
[TBL] [Abstract][Full Text] [Related]
4. Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling.
Chandraskeharan K; Martin PT
Muscle Nerve; 2009 Jan; 39(1):25-41. PubMed ID: 19086062
[TBL] [Abstract][Full Text] [Related]
5. Losartan enhances the success of myoblast transplantation.
Fakhfakh R; Lamarre Y; Skuk D; Tremblay JP
Cell Transplant; 2012; 21(1):139-52. PubMed ID: 21535912
[TBL] [Abstract][Full Text] [Related]
6. Exercise improves the success of myoblast transplantation in mdx mice.
Bouchentouf M; Benabdallah BF; Mills P; Tremblay JP
Neuromuscul Disord; 2006 Aug; 16(8):518-29. PubMed ID: 16919954
[TBL] [Abstract][Full Text] [Related]
7. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
Lala-Tabbert N; Fu D; Wiper-Bergeron N
Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
[TBL] [Abstract][Full Text] [Related]
8. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
Benabdallah BF; Bouchentouf M; Tremblay JP
Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
[TBL] [Abstract][Full Text] [Related]
9. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy.
Abe S; Soejima M; Iwanuma O; Saka H; Matsunaga S; Sakiyama K; Ide Y
Zoolog Sci; 2009 May; 26(5):315-20. PubMed ID: 19715499
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles.
Bouchentouf M; Benabdallah BF; Bigey P; Yau TM; Scherman D; Tremblay JP
Gene Ther; 2008 Mar; 15(6):404-14. PubMed ID: 18079754
[TBL] [Abstract][Full Text] [Related]
11. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
12. Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo.
Cassano M; Dellavalle A; Tedesco FS; Quattrocelli M; Crippa S; Ronzoni F; Salvade A; Berardi E; Torrente Y; Cossu G; Sampaolesi M
Development; 2011 Oct; 138(20):4523-33. PubMed ID: 21903674
[TBL] [Abstract][Full Text] [Related]
13. Myoblast transplantations lead to the expression of the laminin alpha 2 chain in normal and dystrophic (dy/dy) mouse muscles.
Vilquin JT; Guérette B; Puymirat J; Yaffe D; Tomé FM; Fardeau M; Fiszman M; Schwartz K; Tremblay JP
Gene Ther; 1999 May; 6(5):792-800. PubMed ID: 10505103
[TBL] [Abstract][Full Text] [Related]
14. Decorin enhances the proliferation and differentiation of myogenic cells through suppressing myostatin activity.
Kishioka Y; Thomas M; Wakamatsu J; Hattori A; Sharma M; Kambadur R; Nishimura T
J Cell Physiol; 2008 Jun; 215(3):856-67. PubMed ID: 18163379
[TBL] [Abstract][Full Text] [Related]
15. Heat shock treatment increases engraftment of transplanted human myoblasts into immunodeficient mice.
Riederer I; Negroni E; Bigot A; Bencze M; Di Santo J; Aamiri A; Butler-Browne G; Mouly V
Transplant Proc; 2008 Mar; 40(2):624-30. PubMed ID: 18374147
[TBL] [Abstract][Full Text] [Related]
16. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice.
Nakatani M; Takehara Y; Sugino H; Matsumoto M; Hashimoto O; Hasegawa Y; Murakami T; Uezumi A; Takeda S; Noji S; Sunada Y; Tsuchida K
FASEB J; 2008 Feb; 22(2):477-87. PubMed ID: 17893249
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle-derived progenitors capable of differentiating into cardiomyocytes proliferate through myostatin-independent TGF-beta family signaling.
Nomura T; Ueyama T; Ashihara E; Tateishi K; Asada S; Nakajima N; Isodono K; Takahashi T; Matsubara H; Oh H
Biochem Biophys Res Commun; 2008 Jan; 365(4):863-9. PubMed ID: 18047832
[TBL] [Abstract][Full Text] [Related]
20. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
